4SC AG

Four drugs with an orphan designation – Aucatzyl (obecabtagene autoleucel), Blenrep (belantamab mafodotin), Ezmekly (mirdametinib) and Maapliv (amino acids) – are among the 10 new products on track fo

The European Medicines Agency this week recommended against pan-EU marketing approval for two drugs – Vyluma/Nevakar’s Atropine sulfate FGK (atropine) for slowing myopia progression in children, and 4

Germany’s 4SC faces an uncertain future after regulators in Europe dashed any hopes that Kinselby would become the first approved maintenance therapy for cutaneous T-cell lymphoma (CTCL). The Planegg-

The European Medicines Agency has begun reviewing a new batch of drugs for potential pan-EU marketing approval, including resmetirom, Madrigal Pharmaceuticals ’ THR-β agonist, which is awaiting a dec